mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma

B Holmes1,2, A Benavides-Serrato1,2, R S Freeman2

  • 1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Oncogene
|October 24, 2017
PubMed

Insights

Mechanistic target of rapamycin C2 (mTORC2) signaling drives glioblastoma growth by activating heat-shock transcription factor 1 (HSF1) and HuR, which increases Rictor translation and promotes tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Rictor overexpression enhances mechanistic target of rapamycin C2 (mTORC2) activity, promoting glioblastoma multiforme (GBM) growth and invasiveness.
  • The precise mechanisms governing Rictor expression in GBM remain incompletely understood.

Purpose of the Study:

  • To elucidate the regulatory mechanisms controlling Rictor expression in GBM.
  • To investigate the role of heat-shock transcription factor 1 (HSF1) and HuR in Rictor regulation.
  • To identify potential therapeutic targets within the mTORC2/AKT/HSF1/HuR/Rictor signaling pathway.

Main Methods:

  • Investigated Rictor mRNA translation regulation using RNA interference (RNAi) and mutant allele expression.
  • Assessed the binding of HuR to the Rictor 3' untranslated region.
  • Analyzed the activation of HSF1 by mTORC2/AKT signaling.
  • Examined the expression of key signaling components in patient-derived GBM samples.

Main Results:

  • HSF1-induced HuR activity directly binds Rictor mRNA's 3' UTR, enhancing its translational efficiency.
  • mTORC2/AKT signaling activates HSF1, creating a feed-forward loop that sustains Rictor expression and mTORC2 activity.
  • RNAi-mediated inhibition of AKT, HSF1, or HuR significantly downregulates Rictor, inhibiting GBM growth in vitro and in mouse xenografts.
  • Constitutive HuR overexpression maintained Rictor expression despite AKT or HSF1 loss.
  • Expression analysis of GBM patient samples revealed correlative associations supporting the proposed signaling cascade.

Conclusions:

  • A feed-forward loop involving AKT/HSF1/HuR signaling enhances Rictor translation and mTORC2 activity in GBM.
  • Targeting the AKT/HSF1/HuR axis represents a potential therapeutic strategy for GBM.
  • Understanding Rictor translational regulation provides insights into GBM pathogenesis and progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K
Cell Signaling Feedback Loops01:07

Cell Signaling Feedback Loops

Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
7.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K